z-logo
Premium
Preferential expression of IgG2b in nose draining cervical lymph nodes and its putative role in mucosal tolerance induction
Author(s) -
Van Helvoort J. M. L. M.,
Samsom J. N.,
Chantry D.,
Jansen W.,
SchadeeEestermans I.,
Thepen T.,
Mebius R. E.,
Kraal G.
Publication year - 2004
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.2004.00510.x
Subject(s) - lymph , immunology , immune system , lymph node , lymphatic system , biology , isotype , cervical lymph nodes , immune tolerance , antibody , pathology , medicine , metastasis , monoclonal antibody , cancer , genetics
Induction of intranasal tolerance prevents the body from eliciting unwanted immune responses against harmless antigens that enter the body through the nasal mucosa. To study the intrinsic capacities of the cervical, nose draining lymph nodes (CLN), which are essential for tolerance induction, genes that are differentially expressed in CLN and not in peripheral lymph nodes (PLN) were characterized. The gene that is predominantly overexpressed in CLN codes for IgG2b. This is confirmed by a higher percentage of IgG2b + B220 + cells in CLN compared with any PLN. However, this predominance of IgG2b‐positive B cells in the CLN is not specific for the lymph node itself but rather determined by the region drained by lymph nodes at the cervical site, as transplanted PLN at these locations show a comparable predominance. It was demonstrated that IgG2b, when compared with IgG1, led to differential activation of dendritic cells (DC) through Fc receptor signalling. The results point to a unique local combination of cells and factors in the nose draining CLN leading to highly specialized immune reactivity. The results point out that predominance of a distinct IgG isotype in a lymphoid environment may lead to highly specialized immune reactivity.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here